Vol 1 | Issue 1 | July-Sep 2015 | page:16-18 | N B Goyal[1], Gautam Shah[1], Sameer Patil[1], Aashish Ghodke[1].
Authors : N B Goyal[1], Gautam Shah[1], Sameer Patil[1], Aashish Ghodke[1].
[1] Dept. of Orthopaedics,ACPM Medical College and Hospital, Dhule. India.
Address of Correspondence
Dr. N B Goyal
Asso. Proff, Dept of Orthopaedics, ACPM Medical College & Hospital,
Dhule. India.
Email:- nandkishor596@gmail.com
Abstract
Introduction: Chondromyxoid Fibroma [CMF] is a rare, benign, slow-growing bone tumor of cartilaginous origin [1] It typically presents in the long tubular bones [2]. chondromyxoid fibroma with atypical radiographic findings may mimic more common tumors[3].
Case Report: We are hereby reporting a case of Chondromyxoid Fibroma at Distal end of Right Humerus in a 55yrs old Indian female. Patient reported us with swelling since 6 months distal end of Humerus is a rare site for CMF. It represents <0.5% of all bone tumors and is the least common benign tumor of cartilaginous origin [4] Cytological Details, Radiology Findings are discussed in our report.
Conclusion: Distal end of Humerus is a rare site for Chondromyxoid Fibroma which itself is a rare tumor. Tumor has a high recurrance rate. Our aim was to discuss the clinical presentation, diagnosis, prognosis and to show the treatment modality suitable.
Keywords: Chondromyxoid Fibroma, Cartilaginous Tumor, Tubular Bones.
Introduction
Chondromyxoid Fibroma [CMF] is a rare, benign, bone tumor with high recurrence rate [1]. The tumor is considered a physeal plate remnant and may involve the epiphysis, diaphysis, or both along with its metaphyseal origin. It may cause cortical expansion and destruction, but consistently respects the periosteal boundary with distal humerus being an unusual site [2]. Such a case in 55yr yr old female is discussed here where complete excision showed good results with full retur of movement at elbow joint.
Case report
A 55 year old female, housewife, presented with history of swelling over right elbow sine 6 months, which was gradually increased in size over the time. Movements at elbow joint were painful and restricted. There was no history of any fever or any other systemic illness. Physical examination revealed bony hard, immobile, irregular, rough, non-adherent to skin or muscle,3 x 4 cm in size around right lateral condyle of humerus. Pain on movement at elbow joint. No local rise in temperature or distal neurovascular deficit or local rise of temperature. There was no scar, sinus or dilated veins. No significant finding on systemic examination. The patient was seen by local physician and was neglected with prescription of analgesics. X-ray of right elbow AP/LAT view showed well-defined, oval to rounded lytic, eccentrically placed, expansile lesion with sclerotic rim in the epiphyseal region with cortex asymmetrically expanded over of lateral condyle of humerus. Surrounding soft tissue was not involved. CT and MRI was not done. Our clinical differential diagnosis were chondroma, chondromyxoidfibroma, chondroblastoma and chondrosarcoma. Considering the benign nature of history and radiograph a decision of excision biopsy was taken. Complete excision of tumour was done and tumour tissue was sent for histopathological examination for diagnosis which was confirmed as Chondromyxoid fibroma. Histopathology report showed decalcified mass having perichondrium with an outer layer of cartilage as a cap revealing chondrocytic clusters patches of myxomatous tissue with delicate stellate cells, islands of hyaline cartilage and areas of fibrous tissue with cells having varying degree of maturity. No malignant changes were seen. Postoperatively, the patient was fully recovered with no neurological deficit, with full range of flexion and extension at elbow joint without any varus or valgus deformity or any other post-operative complications. Postoperative X-rays showed appropriate joint space and no evidence of residual or recurrence of the tumor mass and patient was returned to full-activity at 1 month post-surgery. One year radiological and clinical follow up confirmed good function and no recurrence.
Discussion
CMF was first described by Jaffe and Lichtenstein in 1948. Chondromyxoid fibroma is a rare, benign, slow-growing bone tumor of cartilaginous origin. Tumor has a high recurrence rate [1]. Classically occurring in the metaphyseal region of the long bones surrounding the knee, but also found with relative frequency in other long bones, the pelvis, ribs, and small foot bones.[2] It accounts for less than 1% of all the primary bone tumors and less than 2% of benign bone tumors. Approximately 80% of the total cases occur in individuals aged 36 years or younger. There is no gender-related difference. To date, no definite etiologies have been documented. It is known that approximately 75% of the total cases of CMF affect the bones of the lower extremities. In particular, it occurs most frequently in the tibia and femur around the knee joint [3]. Clinically, CMF generally has a typical presentation. It usually affects the young with a peak incidence in the second and third decades of life and a slight male preponderance. The patients usually present with pain and swelling of long-standing duration. The sites of predilection are long tubular bones in about half the cases, particularly distal femur and proximal tibia, while in one third of cases flat bones, such as the ileum, are involved. Less common sites include ribs, vertebrae and the bones of skull and hands [4,5]. The tumor is considered as a physeal plate remnant and may involve the epiphysis, diaphysis, or both along with its metaphyseal origin. It may cause cortical expansion and destruction, but consistently respects the periosteal boundary [2]. Chondromyxoid fibroma (CMF) is one such tumor that is characterized by incomplete cartilage differentiation [6]. The helpful features of chondromyxoid fibroma are the peripheral intermediate signal band and central hyperintense signal on T2-weighted images, generally corresponding to the peripheral nodular enhancement and central non-enhancing portion on contrast-enhanced T1-weighted images, respectively [7]. Chonromyxoid tumor are mostly found in long bones and specifically seen in upper end of tibia. Humerus is a rare site but various authors do report it [8-12]. The presentation does not differ in terms of demography or radiology. The management option and prognosis also do not seem to differ. Rare presentation does demand a high index of suspicion for diagnosis and management decisions.
Conclusion
Excision and curettage with placement of cancellous bone graft is good choice of treatment. Post of follow up for at least 3 yrs should be practiced to monitor any recurrence.
Clinical Message
Although CMF is a rare tumor and even rare at distal end of humerus can be treated with good end results. Curretage with placement of cancellous bone graft is good treatment of choice.
References
1. Kirin I, Jurisić D, Mokrović H, Stanec Z, Stalekar H. Chondromyxoid fibroma of the second metacarpal bone–a case report. Coll Antropol. 2011 Sep;35(3):929-31.
2. Slotcavage RL, Dickson BC, Ogilvie CM. Chondromyxoid fibroma involving the
metacarpophalangeal joint. Orthopedics. 2009 Apr;32(4).
3.Chondromyxoid Fibroma of the Finger; So-Min Hwang, Ka-Hyung Cho, Hyung-Do Kim, Yong-Hui Jung, Hong-Il Kim;Arch Plast Surg 2014;41:302-304
\
4.Daneshbod Y, Khademi B. Chondromyxoid fibroma of the mandible: A diagnostic pitfall on aspiration cytology of Parotid. Acta Cytol. 2008;52:636–8.
5.Wolf DA, Chaljub G, Maggo WG, Gelman BB. Intracranial chondromyxoid fibroma. Report of a case and review of literature. Arch Pathol Lab Med. 1997;121:626–30.
6. Walke VA, Nayak SP, Munshi MM, Bobhate SK. Cytodiagnosis of chondromyxoid fibroma. J Cytol. 2010 Jul;27(3):96-8.
7. Kim HS, Jee WH, Ryu KN, Cho KH, Suh JS, Cho JH, Choi YS, Lee SM, Lee JM, Sung MS, Kim JY, Jung ES, Chung YG, Ok IY. MRI of chondromyxoid fibroma. Acta Radiol. 2011 Oct 1;52(8):875-80.
8. Singh J P, Shrimali R, Garg L, Setia V. Chondromyxoid fibroma of humerus. Indian J Radiol Imaging 2002;12:531-2
9. Fujiwara S, Nakamura I, Goto T, Motoi T, Yokokura S, Nakamura K. Intracortical chondromyxoid fibroma of humerus. Skeletal Radiol. 2003 Mar;32(3):156-60.
10. Marin C, Gallego C, Manjón P, Martinez-Tello FJ. Juxtacortical chondromyxoid fibroma: imaging findings in three cases and a review of the literature. Skeletal Radiol. 1997 Nov;26(11):642-9.
11. Dürr HR, Lienemann A, Nerlich A, Stumpenhausen B, Refior HJ. Chondromyxoid fibroma of bone. Arch Orthop Trauma Surg. 2000;120(1-2):42-7.
12. Bhamra JS, Al-Khateeb H, Dhinsa BS, Gikas PD, Tirabosco R, Pollock RC, Skinner JA, Aston WJ, Saifuddin A, Briggs TW. Chondromyxoid fibroma management: a single institution experience of 22 cases. World J Surg Oncol. 2014 Sep 12;12:283.
| How to Cite this Article: Goyal NB, Shah G, Patil S, Ghodke A. Chondromyxoid Fibroma of Humerus[CMF] – A Rare Case Report. International Journal of Surgical Cases 2015 July-Sep;1(1): 16-18. |
